In interim data presented this spring, investigators found that patients experiencing medication-driven weight loss showed a significant reduction in adipose-derived stem cells cells involved in tissue regeneration and structural support.[2] That may help explain why some people notice: hollow cheeks and temples, crepey or loose skin, increased dryness, more visible wrinkles, sagging around the jawline, and skin that suddenly looks tired or deflated
#ObesityMedicine #GLP1 #Semaglutide #PrecisionMedicine #CardiometabolicHealth #Endocrinology #ClinicalTrials #MetabolicHealth #BodyComposition #ArtificialIntelligence #PreventiveCardiology #HealthcareInnovation #TranslationalMedicine #MedicalResearch #DigitalHealth #LongevityMedicine #MuscleHealth #Cardiology #WeightManagement #HealthTech To view or add a comment, sign in More Relevant Posts |
Mitochondria, the powerhouses of our cells, make a lot of free radicals as a byproduct of their normal activity: creating energy
Although no improvement of cardiovascular outcomes was observed, linagliptin showed a better management of blood glucose with a higher rate of maintaining HbA1c below 7.0% (16.0% vs
Thats where retatrutide enters the picture
However, when patients stop taking these drugs, they not only regain weight, but, according to a new study, they also incur increased risk of heart attack, stroke and death compared to staying on the medication